162 related articles for article (PubMed ID: 34689350)
1. Allele and genotype frequencies of CYP3A4, CYP3A5, CYP3A7, and GSTP1 gene polymorphisms among mainland Tibetan, Mongolian, Uyghur, and Han Chinese populations.
Qi G; Han C; Zhou Y; Wang X
Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):219-227. PubMed ID: 34689350
[TBL] [Abstract][Full Text] [Related]
2. CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation.
Dong Y; Xu Q; Li R; Tao Y; Zhang Q; Li J; Ma Z; Shen C; Zhong M; Wang Z; Qiu X
Gene; 2022 Jan; 809():146007. PubMed ID: 34688813
[TBL] [Abstract][Full Text] [Related]
3. CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic range proteinuria.
Liu H; Xu Q; Huang W; Zhao Q; Jiang Z; Kuang X; Li Z; Sun H; Qiu X
Eur J Clin Pharmacol; 2019 Nov; 75(11):1533-1540. PubMed ID: 31401678
[TBL] [Abstract][Full Text] [Related]
4. Genetic contribution to variable human CYP3A-mediated metabolism.
Lamba JK; Lin YS; Schuetz EG; Thummel KE
Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
[TBL] [Abstract][Full Text] [Related]
5. Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.
Qi GZ; Zhang ZY; Wang X; Yin SJ; Lou YQ; Zhang GL
J Clin Pharm Ther; 2016 Feb; 41(1):84-91. PubMed ID: 26763760
[TBL] [Abstract][Full Text] [Related]
6. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.
Zuo LJ; Guo T; Xia DY; Jia LH
Genet Test Mol Biomarkers; 2012 Feb; 16(2):102-8. PubMed ID: 22224559
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of the drug-metabolizing enzyme cytochrome P450 3A5 in a Uyghur Chinese population.
Chen Z; Li J; Chen P; Wang F; Zhang N; Yang M; Jin T; Chen C
Xenobiotica; 2016 Sep; 46(9):850-6. PubMed ID: 26739429
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
Zuo J; Xia D; Jia L; Guo T
Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 (CYP3A4*18) and glutathione-S-transferase (GSTP1) polymorphisms in a healthy Tunisian population.
Zaied C; Abid S; Mtiraoui N; Zellema D; Achour A; Bacha H
Genet Test Mol Biomarkers; 2012 Oct; 16(10):1184-7. PubMed ID: 22971138
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population.
Salameh G; Al Hadidi K; El Khateeb M
Environ Toxicol Pharmacol; 2012 Jul; 34(1):23-33. PubMed ID: 22426036
[TBL] [Abstract][Full Text] [Related]
11. Modifying Role of GSTP1 Polymorphism on the Association between Tea Fluoride Exposure and the Brick-Tea Type Fluorosis.
Wu J; Wang W; Liu Y; Sun J; Ye Y; Li B; Liu X; Liu H; Sun Z; Li M; Cui J; Sun D; Yang Y; Gao Y
PLoS One; 2015; 10(6):e0128280. PubMed ID: 26046522
[TBL] [Abstract][Full Text] [Related]
12. CYP3A5*3 and MDR-1 C3435T single nucleotide polymorphisms in six Chinese ethnic groups.
Lai Y; Zhang J; Wang YX; Wang XD; Li JL; Wang YH; Zeng YJ; Huang M
Pharmazie; 2011 Feb; 66(2):136-40. PubMed ID: 21434577
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of drug metabolizing phase-I enzymes CYP3A4 in Tibetan populations.
Liu L; Chang Y; Du S; Shi X; Yang H; Kang L; Jin T; Yuan D; He Y
J Genet; 2017 Jun; 96(2):219-225. PubMed ID: 28674221
[TBL] [Abstract][Full Text] [Related]
14. CYP3A Polymorphism and Chronic Mercury Intoxication.
Chernyak YI; Merinova AP
Bull Exp Biol Med; 2020 Feb; 168(4):492-495. PubMed ID: 32146629
[TBL] [Abstract][Full Text] [Related]
15. CYP3A4 and CYP3A5 genotyping by Pyrosequencing.
Garsa AA; McLeod HL; Marsh S
BMC Med Genet; 2005 May; 6():19. PubMed ID: 15882469
[TBL] [Abstract][Full Text] [Related]
16. Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients.
Sun B; Guo Y; Gao J; Shi W; Fan G; Li X; Qiu J; Qin Y; Liu G
Pharmacogenomics; 2017 Nov; 18(16):1503-1513. PubMed ID: 28952408
[TBL] [Abstract][Full Text] [Related]
17. Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina.
Semiz S; Dujić T; Ostanek B; Prnjavorac B; Bego T; Malenica M; Mlinar B; Marc J; Causević A
Med Glas (Zenica); 2011 Feb; 8(1):84-9. PubMed ID: 21263403
[TBL] [Abstract][Full Text] [Related]
18. CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.
Hu YF; He J; Chen GL; Wang D; Liu ZQ; Zhang C; Duan LF; Zhou HH
Clin Chim Acta; 2005 Mar; 353(1-2):187-92. PubMed ID: 15698606
[TBL] [Abstract][Full Text] [Related]
19. Deciphering DMET genetic data: comprehensive assessment of Northwestern Han, Tibetan, Uyghur populations and their comparison to eleven 1000 genome populations.
Zhang J; Wang H; Niu G; Liu Y; Wang Y; Zhang L; Pei Y; Zhu H; Dai P; Chen C
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1176-S1185. PubMed ID: 30688101
[TBL] [Abstract][Full Text] [Related]
20. Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip.
Liu CH; Peck K; Huang JD; Lin MS; Wang CH; Hsu WP; Wang HW; Lee HL; Lai ML
Pharmacogenomics; 2005 Oct; 6(7):731-47. PubMed ID: 16207150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
